QuidelOrtho Q4 EPS $0.46 Beats by 7.8%, Revenues Top $723.6M
QuidelOrtho posted Q4 adjusted EPS of $0.46 versus $0.43 expected and revenue of $723.6M, topping estimates by 3.6% and rising from $707.8M a year ago. Consensus for Q1 is $0.80 EPS on $719.3M revenue, with the medical products industry in the bottom 32%.
1. Q4 Financial Results
QuidelOrtho reported adjusted Q4 EPS of $0.46, beating the $0.43 consensus by 7.8% but down from $0.63 a year earlier. Revenue reached $723.6 million, surpassing estimates by 3.6% and up 2.2% from $707.8 million in the prior-year period.
2. Forward Guidance and Industry Context
Analysts project Q1 EPS of $0.80 on $719.3 million revenue, with full-year forecasts of $2.49 EPS on $2.77 billion. The medical products segment ranks in the bottom 32% of its industry, shares are up 2.3% year-to-date versus the S&P 500’s 1.4%, and a #4 rating signals potential underperformance.